Creative Planning’s Ginkgo Bioworks DNA Stock Holding History

Creative Planning’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157K	Buy	+15,840	New	+$132K	﹤0.01%	3950
2024 Q3	–	Sell	-797	Closed	-$10.7K	–	3228
2024 Q2	$10.7K	Sell	797 -444	-36%	-$13.2K	﹤0.01%	3015
2024 Q1	$57.6K	Sell	1,241 -130	-9%	-$6.73K	﹤0.01%	2771
2023 Q4	$92.7K	Sell	1,371 -178	-11%	-$10.9K	﹤0.01%	2581
2023 Q3	$112K	Buy	1,549 +558	+56%	+$44.6K	﹤0.01%	2377
2023 Q2	$73.7K	Buy	991 +701	+242%	+$41.5K	﹤0.01%	2396
2023 Q1	$15.4K	Sell	290 -78	-21%	-$4.94K	﹤0.01%	2429
2022 Q4	$24.9K	Buy	+368	New	+$33.8K	﹤0.01%	2302
2021 Q4	–	Sell	-682	Closed	-$316K	–	2119
2021 Q3	$316K	Buy	+682	New	+$332K	﹤0.01%	1559

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Creative Planning's DNA Position: Q2 2026 in Review

Creative Planning opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 15,840 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #3950 among its holdings. This is a return to the name: Creative Planning previously reported a position in DNA as recently as Q2 2024.

Creative Planning first reported a position in DNA in Q3 2021 and has held it in 9 quarters since. The position peaked at $316K in Q3 2021. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Creative Planning held 15,840 shares of Ginkgo Bioworks worth $157K as of Q2 2026.
Ginkgo Bioworks was a new Creative Planning position in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3950 holding.
Creative Planning first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 9 quarters since.
Creative Planning's Ginkgo Bioworks position peaked at $316K in Q3 2021.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.